Jabak's Visit To Oman Began With The Global Meeting Of The Arab Health Ministers

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A10BJ06	OZEMPIC	B	Semaglutide - 0.5mg	0.5mg	Injectable solution	10,927,526 L.L
G04BE08	CIALIS	B	Tadalafil - 20mg	20mg	Tablet, film coated	3,101,588 L.L
J07AL01	PNEUMOVAX 23	B	Polysaccharides from each of 23 capsular types of Streptococcus pneumoniae - 25mcgx23serotypes/0.5ml		Injectable solution	2,378,601 L.L
N02AB03	ABSTRAL	B	Fentanyl (citrate) - 100mcg	100mcg	Tablet	3,419,743 L.L
A07EA06	BUDENOFALK	B	Budesonide - 3mg	3mg	Capsule	8,554,692 L.L
A10BJ06	OZEMPIC	B	Semaglutide - 1mg	1mg	Injectable solution	10,927,526 L.L
C09CA03	DIOVAN	B	Valsartan - 80mg	80mg	Tablet, film coated	602,041 L.L
J07AL02	PREVENAR 13	B	Polysaccharide for serotypes 1, 3, 4, 5 , 6A, 7F, 9V,14, 18C, 19A, 19F, 23F (2.2mcg)Polysaccharide for serotypes 6B (4.4mcg)Conjugated to CRM197 carrier protein and adsorbed on aluminium phosphate (0.125mg aluminium) -		Injectable suspension	6,352,343 L.L
N06AB05	SEROXAT CR	B	Paroxetine (HCl) - 12.5mg	12.5mg	Tablet, controlled release	2,371,608 L.L
R01AD12	AVAMYS	B	Fluticasone furoate - 27.5mcg/dose	27.5mcg/dose	Suspension	722,987 L.L
J07AL02	SYNFLORIX	B	Polysaccharide from each of 10 capsular types of pneumococcus (conjugated to carrier proteins) adsorbed onto aluminium phosphate - 1mcg/0.5ml, Polysaccharide of serotypes 41,2, 18C1,3 and 19F1,4 - 3mcg/0.5ml, 1 adsorbed onto aluminium phosphate - 0.5mg Al3+, 2 conjugated to protein D (derived from NTHi) carrier protein - ~ 13mcg, 3 conjugated to tetanos toxoid carrier protein - ~ 8mcg, 4 conjugated to diphteria toxoid carrier protein - ~ 5mcg		Injectable suspension	4,675,228 L.L
N02AJ06	EFFERALGAN CODEINE	B	Paracetamol - 500mg, Codeine phosphate - 30mg		Tablet, effervescent scored	215,015 L.L
N06AB05	SEROXAT CR	B	Paroxetine (HCl) - 25mg	25mg	Tablet, controlled release	2,845,587 L.L
R01AD12	AVAMYS	B	Fluticasone furoate - 27.5mcg/dose	27.5mcg/dose	Suspension	722,987 L.L
A10BK01	FORXIGA	B	Dapagliflozin - 10mg	10mg	Tablet, film coated	2,927,964 L.L
B02BC30-V03AK	TISSEEL LYO	B	Fibrinogen, human (clottable protein) (I) - 91mg/ml, Aprotinin, synthetic (I) - 3000KIU/ml, Thrombin, Human (II) - 500IU/ml, Calcium chloride (II) - 40?mol/ml		Injectable powder for solution + solution	53,437,592 L.L
L01EF01	IBRANCE	B	Palbociclib - 125mg	125mg	Capsule	172,164,216 L.L
M01AE01	ALGIFAST 400	B	Ibuprofen Lysine - 400mg	400mg	Powder for suspension	473,033 L.L
N02AJ06	EFFERALGAN CODEINE	B	Paracetamol - 500mg, Codeine phosphate - 30mg		Tablet, film coated	215,015 L.L
N06AB06	ZOLOFT	B	Sertraline HCl - 50mg	50mg	Tablet, scored	596,666 L.L
R01AD58	DYMISTA	B	Fluticasone propionate - 50mcg/actuation, Azelastine HCl - 137mcg/actuation		Spray, suspension	2,183,744 L.L
A07EA06	CORTIMENT MMX	B	Budesonide - 9mg	9mg	Tablet, prolonged release	8,996,996 L.L
B02BC30-V03AK	TISSEEL LYO	B	Fibrinogen, human (clottable protein) (I) - 91mg/ml, Aprotinin, synthetic (I) - 3000KIU/ml, Thrombin, Human (II) - 500IU/ml, Calcium chloride (II) - 40?mol/ml		Injectable powder for solution + solution	24,369,850 L.L
J07AL02	PREVENAR 20	B	Pneumococcal polysaccharide for serotypes 1, 3, 4, 5 , 6A, 7F,8, 9V,10A, 11A, 12F, 14, 15B, 18C, 19A, 19F,22F, 23F, 33F (2.2mcg) Pneumococcal polysaccharide for serotypes 6B (4.4mcg)Conjugated to CRM197 carrier protein (approximately 51mcg) adsorbed on aluminium phosphate (0.125mg aluminium) -		Injectable suspension	7,415,107 L.L
L01EF01	IBRANCE	B	Palbociclib - 125mg	125mg	Tablet, film coated	172,164,216 L.L
M01AE01	ALGIFAST PEDIATRIC	B	Ibuprofen Lysine - 20mg/ml	20mg/ml	Suspension	393,746 L.L
N06AB06	ZOLOFT	B	Sertraline HCl - 50mg	50mg	Tablet, scored	596,666 L.L
A07EC02	ASACOL	B	Mesalazine - 400mg	400mg	Tablet, enteric coated	5,895,437 L.L
B02BC30-V03AK	TISSEEL LYO	B	Fibrinogen, human (clottable protein) (I) - 91mg/ml, Aprotinin, synthetic (I) - 3000KIU/ml, Thrombin, Human (II) - 500IU/ml, Calcium chloride (II) - 40?mol/ml		Injectable powder for solution + solution	13,394,024 L.L
D07XA01	DAKTACORT	B	Hydrocortisone - 10mg/g, Miconazole nitrate - 20mg/g		Cream	208,296 L.L

Jabak's visit to Oman began with the global meeting of the Arab Health Ministers